Biofil Chemicals & Pharmaceuticals (BOM:524396) E10: ₹0.00 (As of Mar. 2026)


BOM:524396 Biofil Chemicals & Pharmaceuticals Ltd BOM:524396
73 GF Score
Price ₹34.04
GF Value ₹41.82
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Biofil Chemicals & Pharmaceuticals E10?

Biofil Chemicals & Pharmaceuticals BOM:524396 +0.29% 73 E10 is ₹0.00 as of Mar. 2026. GuruFocus rates BOM:524396 with a GF Score™ of 73/100 and a GF Value™ of ₹41.82 (Modestly Undervalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biofil Chemicals & Pharmaceuticals's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹0.00 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Biofil Chemicals & Pharmaceuticals's average E10 Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Biofil Chemicals & Pharmaceuticals was 3.50% per year. The lowest was 1.00% per year. And the median was 2.25% per year.

As of today (2026-07-05), Biofil Chemicals & Pharmaceuticals's current stock price is ₹34.04. Biofil Chemicals & Pharmaceuticals's E10 for the quarter that ended in Mar. 2026 was ₹0.00. Biofil Chemicals & Pharmaceuticals's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Biofil Chemicals & Pharmaceuticals was 550.33. The lowest was 32.59. And the median was 78.54.


Biofil Chemicals & Pharmaceuticals  (BOM:524396) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Biofil Chemicals & Pharmaceuticals was 550.33. The lowest was 32.59. And the median was 78.54.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Biofil Chemicals & Pharmaceuticals E10 Related Terms


Biofil Chemicals & Pharmaceuticals E10 Historical Data

* Premium members only.

The historical data trend for Biofil Chemicals & Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofil Chemicals & Pharmaceuticals E10 Chart

Biofil Chemicals & Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 0.72 0.72 0.71 0.00

Biofil Chemicals & Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 0.85 0.86 0.86 0.00

BOM:524396 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Biofil Chemicals & Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biofil Chemicals & Pharmaceuticals Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofil Chemicals & Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biofil Chemicals & Pharmaceuticals's Shiller PE Ratio falls into.


BOM:524396
73GF Score
Biofil Chemicals & Pharmaceuticals Ltd BOM:524396
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biofil Chemicals & Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biofil Chemicals & Pharmaceuticals's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0/164.2724*164.2724
=0.000

Current CPI (Mar. 2026) = 164.2724.

Biofil Chemicals & Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201606 0.020 105.961 0.031
201609 0.168 105.961 0.260
201612 0.302 105.196 0.472
201703 0.620 105.196 0.968
201706 0.060 107.109 0.092
201709 0.040 109.021 0.060
201712 0.140 109.404 0.210
201803 0.050 109.786 0.075
201806 0.040 111.317 0.059
201809 0.060 115.142 0.086
201812 0.180 115.142 0.257
201903 0.200 118.202 0.278
201906 0.020 120.880 0.027
201909 0.490 123.175 0.653
201912 0.140 126.235 0.182
202003 0.090 124.705 0.119
202006 0.130 127.000 0.168
202009 0.570 130.118 0.720
202012 0.310 130.889 0.389
202103 -0.250 131.771 -0.312
202106 0.110 134.084 0.135
202109 0.130 135.847 0.157
202112 0.210 138.161 0.250
202203 -0.010 138.822 -0.012
202206 0.130 142.347 0.150
202209 0.030 144.661 0.034
202212 0.060 145.763 0.068
202303 0.120 146.865 0.134
202306 0.150 150.280 0.164
202309 0.080 151.492 0.087
202312 0.060 152.924 0.064
202403 0.160 153.035 0.172
202406 0.100 155.789 0.105
202409 0.010 157.882 0.010
202412 0.100 158.323 0.104
202503 0.120 157.552 0.125
202506 1.480 159.755 1.522
202509 0.050 162.289 0.051
202512 0.050 163.281 0.050
202603 0.000 164.272 0.000

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹0.00 mean?
Biofil Chemicals & Pharmaceuticals (BOM:524396) has a E10 of ₹0.00 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Biofil Chemicals & Pharmaceuticals and its competitors.
Is Biofil Chemicals & Pharmaceuticals' E10 too high?
Biofil Chemicals & Pharmaceuticals' current E10 is ₹0.00. Overall, Biofil Chemicals & Pharmaceuticals has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Biofil Chemicals & Pharmaceuticals' E10 compare to ZTS and UTHR?
Biofil Chemicals & Pharmaceuticals' E10 of ₹0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Biofil Chemicals & Pharmaceuticals and its competitors. Biofil Chemicals & Pharmaceuticals's current E10 is ₹0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biofil Chemicals & Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Biofil Chemicals & Pharmaceuticals (BOM:524396) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹41.82, compared to a current price of ₹34.04 — trading 18.6% below its estimated fair value. The current E10 is ₹0.00. Biofil Chemicals & Pharmaceuticals' overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Biofil Chemicals & Pharmaceuticals (BOM:524396), the current E10 is ₹0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biofil Chemicals & Pharmaceuticals (BOM:524396) Overvalued in 2026?

Based on GuruFocus' analysis, Biofil Chemicals & Pharmaceuticals stock appears to be undervalued. The current stock price of ₹34.04 is trading 18.6% below its estimated GF Value™ of ₹41.82. GuruFocus considers Biofil Chemicals & Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for BOM:524396:

  • E10: ₹0.00
  • GF Value™: ₹41.82 vs. price of ₹34.04 (18.6% below fair value)
  • GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the BOM:524396 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biofil Chemicals & Pharmaceuticals Business Description

Other Exchanges BIOFILCHEM:India
Address 11/12, Sector E Sanwer Road, Industrial Area, Indore, MP, IND, 452015
Biofil Chemicals & Pharmaceuticals Ltd is an Indian pharmaceutical company. It deals in the manufacturing and trading of pharmaceuticals. Further, the company also deals in providing job work facilities with respect to the manufacturing of pharmaceutical drugs. Its product portfolio comprises basic drugs and pharmaceuticals such as sodium citrate, sodium chloride, ferrous sulphate, micro crystalline cellulose, dicyclomine hydrochloride, and others. The company's operating segments are: Pharma, which derives maximum revenue, and Chemicals. Geographically, it caters to both domestic and international markets.
73GF Score

Get the complete analysis for BOM:524396

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹34.04
Price
₹41.82
GF Value